Roche Holding AG (RHHBY)
Develops medicines and diagnostic tests to detect and treat diseases like cancer and diabetes.
$56.38+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+45.2%
The outlook
RHHBY is trading above both its 50- and 200-day moving averages, sitting near the higher end of its 52-week range. Analyst consensus leans bullish with a Buy rating, though the average price target sits about 2% above the current price. The stock trades at a trailing P/E of 24.1 with modest upside implied by current analyst expectations.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 7 analysts
Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Price targetAvg target +2% vs current price
Analyst price target
~12-month · 7 analysts$57.23average target+1.5% vs now
Now $56.38
Low $46.00High $67.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$359.37B
52-wk high
$60.85
52-wk low
$37.51
50-day avg
$51.50
200-day avg
$50.88
Trailing P/E
24.1